Altimmune, Inc. (ALT) Tops Q4 EPS by 1c

Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• DWS Municipal Income Trust sets November 2026 liquidation timeline
• Blue Star Gold closes $947,631 non-brokered private placement